Now showing items 1-5 of 5
Estimation of Ten-Year survival of patients with pulmonary tuberculosis based on the competing risks model in Iran
© 2016 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran. Background: Tuberculosis (TB) is a chronic bacterial disease, which despite the presence of effective drug strategies, still remains a ...
A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis
© 2016 The Author(s). Background: Tuberculosis (TB) and tobacco use are two major alarming global health issues that tend to be co-prevalent in many developing countries and various surveys have provided evidence on their ...
Tuberculosis-associated secondary pneumothorax: A retrospective study of 53 patients
BACKGROUND Pneumothorax is a well known complication of pulmonary tuberculosis (TB), particularly in patients with advanced TB. METHODS: At our national TB-referral hospital, we compared the medical records of 53 TB patients ...
Serum copper (Cu) alterations in pulmonary tuberculosis patients under treatment with ethambutol
Ethambutol is an oral anti-tuberculosis agent with chelating effects owing to its chemical structure which is similar to that of penicillamine. Copper (Cu) is an essential trace element that has important roles in physiological ...
Effect of antituberculosis regimen containing ethambutol on serum magnesium level in pulmonary tuberculosis patients
Magnesium is an essential metal that has important roles in physiological function of the body organs. Ethambutol is an oral antitubercular agent with chelating effects owing to its chemical structure. The aim of present ...